Cellular Therapy Innovations in Asia

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of Genetic Technology TOE depicts trends in cellular therapies across Asia. Cell therapies enable to address a broad spectrum of health concerns associated to multiple disease areas. The corresponding patent scenario for stem cell therapeutics is depicted along with industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative

Table of Contents

Cellular Therapy Innovations in AsiaTechnology ProfilesTaiwan Biotechnology Firm Develops Mesenchymal Stem Cell (MSC) Therapeutics T-Cell Therapies Being Actively Researched and Developed in South Korea Stem Cell Services Advance Rapidly across India Indian Regenerative Medicine-based Therapeutic SolutionsAppendixRecent Patents Related to Stem Cell Therapeutics in Asia Industry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.